
Desaturation during Physical Exercise in COPD Patients – a Stable-over-time Phenomenon
Author(s) -
Roman Kalinov,
Blagoi Marinov,
D Stoyanova,
Vladimir Hodgev,
L. Vladimirova-Kitova,
Fedya Nikolov,
Stefan Kostianev
Publication year - 2019
Publication title -
folia medica/folia medica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.245
H-Index - 21
eISSN - 1314-2143
pISSN - 0204-8043
DOI - 10.2478/folmed-2018-0079
Subject(s) - medicine , copd , oxygen saturation , cardiology , anesthesia , oxygen , chemistry , organic chemistry
Exercise-induced desaturation is a common finding in patients with moderate and severe COPD. It is an important marker in the course of disease that has a prognostic value for mortality risk. Aim: To monitor over time COPD patients with and without desaturation during 6-minute walking test (6MWT) and to assess the stability of that phenomenon. Materials and methods: A 6MWT was administered to 70 patients with COPD which ranged in severity from stage 2A to stage 4D (GOLD 2011); the patients had a mean age of 64.5±10.1, mean pack-years - 38.8±21, FEV 1 % = 46.4%±15.7%, FVC% = 73.7%±1.3%, MRC = 2.31±0.84, CAT = 20.8±6.6. Oxygen saturation was monitored during the test; indications for desaturation were a decrease of SpO 2 by ≥4% and a fall in SpO 2 to ≤88% for at least 3 min. The patients were followed-up for mean 40.9±22.3 months and tests were repeated. Results: Patients were divided into two groups based on the decrease in SpO2: Group A included patients with desaturation (n=35) and Group B – patients with no desaturation (n=35). In 66 of the patients the desaturation profile was stable over time. Only two patients, who did not desaturated at baseline, experienced desaturation in the follow-up 6MWT and another two patients, who desaturated at baseline, did not have it later in the follow-up. Conclusion: Desaturation is a phenomenon that is persistent over time. Based on the results, it could be concluded that exercise-induced desaturation is a major marker of a particular COPD phenotype.